Impact of Physical Activity on Quality of Life for Chronic Hemodialysis Patients
QDV-HD
1 other identifier
observational
750
1 country
2
Brief Summary
Chronic end-stage renal disease has a significant impact on patients' quality of life. In 2005, a study evaluating the quality of life of patients with end-stage chronic kidney disease using the SF-36 and KDQoL questionnaires showed that the proportion of patients with an altered quality of life varied from 20% to 50% in the physical component dimensions and from 12% to 47% in the mental component dimensions. More than 75% of dialysis patients had at least one of the 8 scores below the threshold that defines impaired quality of life. In 2011, the Quavi-REIN study involved 1251 dialysis patients showed a significant reduction of quality of life assessed using the generic SF36 questionnaire compared with the general population, in the physical and mental dimensions. Moreover, in France, more than one senior citizens aged between 55 and 74 in three does not comply with the World Health Organisation's recommendations on the minimum level of physical activity required per day. A sedentary lifestyle is a major public health problem. It is the 4thrisk factor for mortality after hypertension, smoking and diabetes. This inactivity increases mortality and morbidity rates in humans, and consequently the risk of diseases such as cancer and type 2 diabetes. Physical activity is recommended for patients with chronic kidney disease. In a survey of 505 nephrologists, 97% thought that physical activity is beneficial for dialysis patients, given that a sedentary lifestyle increases the death rate among dialysis patients. Data from the international DOPPS registry, involving 20,920 patients, showed that patients who engage in physical activity have a better quality of life (physical, psychological and sleep quality components), as assessed by the KDQoL-SF questionnaire.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2023
CompletedFirst Posted
Study publicly available on registry
November 29, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedNovember 29, 2023
November 1, 2023
2 months
November 20, 2023
November 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Health-related quality of life using SF-36 survey
Health-related quality of life will be evaluated by the generic questionnaire "Medical Outcomes Study ShortForm General Health Survey" (SF-36) created in 1992 by Ware and Sherbourne and validated in French by Leplège in 1998 The SF-36 is a questionnaire containing 36 items, covering the four weeks preceding the time when the subject is interviewed, grouped into 8 dimensions. Each question is assessed on a Likert scale, with 3, 5 or 6 possible answer levels. The score for each dimension varies from 0 to 100, the higher the score and the better the quality of life.
Day 0
Secondary Outcomes (2)
Health-related quality of life using KDQOL survey
Day 0
Physical activity using RICCI GAGNON test
Day 0
Study Arms (1)
Chronic hemodialysis patients
patients with chronic hemodialysis
Interventions
Eligibility Criteria
patients with chronic hemodialysis
You may qualify if:
- Hemodialysis
- Major
- Agreeing to participate in the study
You may not qualify if:
- On peritoneal dialysis
- On daily dialysis at home
- Minors
- Protected by law (guardianship, curatorship, safeguarding of justice)
- Refusing to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Ufr Medecine Urca
Reims, 51100, France
Université de Reims Champagne Ardenne
Reims, 51100, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2023
First Posted
November 29, 2023
Study Start
January 1, 2024
Primary Completion
March 1, 2024
Study Completion
July 1, 2024
Last Updated
November 29, 2023
Record last verified: 2023-11